US 12,488,918

Application 17/785,044 · Granted Dec 2, 2025

Neodymium-iron-boron magnet material, raw material composition preparation method, and application

Estimated expiration

July 1, 2042

15y 225d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTCN2021077178: Resource not found (404)
Earliest effective filing
Feb 22, 2021
+ 20 years
Feb 22, 2041
PTA +494d
Jul 1, 2042
No TD
—
Final
Jul 1, 2042

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
June 13, 2022
Earliest effective filing
February 22, 2021
Issue date
December 2, 2025
PTA
+494 days
Base expiry (before PTA)
February 22, 2041

February 22, 2021 + 20 years = February 22, 2041 + 494 PTA days = July 1, 2042

  • National stage entry of application PCTCN2021077178, filed Feb 22, 2021

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/785,044 · US 12,488,918

PatentReply compiles the prosecution history behind US 12,488,918: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12488918

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.